Tracey Childs, our newest Curant Cares award winner! Congratulations to Tracey Childs, Office Administrator in our Georgia location, for being nominated as our third recipient of the Curant Cares Award! Tracey takes her responsibilities toward our patients and our Curant team members to the next level of helpfulness, assistance and value. Tracey goes above and […]
Prior to Armada 2015, my colleagues and I spoke about the dire need for greater alignment among all stakeholders in the pharmaceutical industry. While there have been some advancements in this regard over the past 12 months, they are painfully slow and need acceleration. Within their individual silos, manufacturers and payers continue delivering for their […]
April 12, 2016 - Curant Health COO, Marc O'Connor, featured in Managed Healthcare Executive - #4. Don’t overlook the capability specialty pharmacy partners. “Engagement with specialty pharmacy partners with proven MTM programs has shown to add measurable value, improve medication adherence, patient outcomes and reduce overall healthcare costs,” according to Marc O’Connor, COO with medication management […]
April 11, 2016 - Curant COO, Marc O'Connor, in Specialty Pharmacy Times - FACT: THE AFFORDABLE CARE ACT (ACA) succeeded in increasing the number of insured Americans. According to the National Center for Health Statistics, there were 16 million fewer uninsured Americans as of September 2015, than in 2013. More specifically, the percentage of uninsured […]
April 8, 2016 - Curant President and CEO, Patrick Dunham, featured in Managed Healthcare Executive - Statin intolerance does exist and a PCSK9 inhibitor can lower cholesterol in these patients, according to a study published online in JAMA and presented at the American College of Cardiology's 65th Annual Scientific Session in Chicago. In the first […]
There is a change underway in the specialty pharmacy patient experience. First and foremost, the patient and the patient’s direct care team - providers, clinicians and specialists - are focused on putting patient outcomes above anything else. Why? It’s simple: the costs associated with not attaining improved patient outcomes have a domino effect on all players […]
April 1, 2016 – Atlanta, Georgia – One of the nation’s largest independent 340B specialty pharmacies, Curant Health, announces the launch of seven new 340B clinic partnerships beginning April 1, 2016: Columbus Department of Public Health - Ryan White (Columbus, GA) Florida Department of Health in Desoto County - Ryan White (Arcadia, FL) Florida Department […]
The backstory The relationship between medication adherence and wasted healthcare spend is generally uncomplicated in nature; one component can negatively or positively impact the other. In reality, when medication adherence is improved, the amount in wasted healthcare spend long-term is lowered. When news broke recently that $3 billion is wasted on cancer drugs every year […]
March 22, 2016 - Curant COO, Marc O'Connor, in MedCity News - We have long known that improvements in medication adherence are the longest lever available to impact wasteful healthcare spending in the United States. We know further that improvements in adherence affect both variables of the value equation in the right direction: improving outcomes and […]
There are a number of items that influence medication spend, including specialty drug costs, medication adherence and patient outcomes. However, there’s another item out there that may be driving up medication cost unnecessarily. What we know There are 3 well-known drivers that contribute to medication spending in the U.S.: Massive increase in number and cost […]
